Hypoxen 250 mg 30 capsules
Semax nasal drops 0.1% 3 ml
Plaquenil 200 mg 60 tablets
Prednisolone 5mg 100 tablets
Cerebrolysin 5 ml 5 vials
Sialis 5 mg 14 tablets
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
Avodart 0,5 mg 90 capsules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Combilipen 30 tablets
Mydocalm 1 ml 5 vials
Selank 0.15% nasal drops
Persen 20 tablets
Cogitum 10 ml 30 vials
Mydocalm 50 mg 30 tablets
Actovegin 200 mg 50 tablets
Mydocalm 150 mg 30 tablets
Phezam 400/25 mg 60 Capsules
Cerebrolysin 2 ml 10 vials
Axamon 20 mg 50 tablets
Persen night 10 capsules
betaserc 8 mg 30 tablets
Reminyl 8 mg 7 capsules
Ceraxon 1000 mg/4 ml 5 vials
Persen night 40 capsules
Trileptal 150 mg 50 tablets
Vasobral 30 tablets
Vinpotropil 30 capsules
Midantan 100 mg 100 tablets
Betahistine 24 mg 60 tablets
VIFERON-4 3000000ME 10 suppositories
Manufacturer: Feron
Country of origin: Russia
General description: Cytokine
Pharmacological action
Interferon alfa-2b human recombinant possesses antiviral, immunomodulatory, antiproliferative properties, suppresses the replication of RNA and DNA-containing viruses. Immunomodulatory properties of interferon alfa-2b, such as an increase in the phagocytic activity of macrophages, an increase in the specific cytotoxicity of lymphocytes to target cells, cause its mediated antibacterial activity.
In the presence of ascorbic acid and alpha-tocopherol acetate, the specific antiviral activity of interferon alfa-2b increases, its immunomodulating effect increases, which allows increasing the efficiency of the organism's own immune response to pathogenic microorganisms. When using the drug, the level of secretory immunoglobulins class A increases, the level of immunoglobulin E normalizes, and the endogenous system of interferon alfa-2b is restored. Ascorbic acid and alpha-tocopherol acetate, being highly active antioxidants, have anti-inflammatory, membrane-stabilizing, and regenerating properties. It was found that when Viferon® is used, there are no side effects arising from the parenteral administration of interferon alfa-2b preparations, antibodies that neutralize the antiviral activity of interferon alfa-2b are not formed. The use of the drug Viferon ® as a part of complex therapy allows to reduce therapeutic doses of antibacterial and hormonal drugs, as well as to reduce the toxic effects of this therapy.
Cocoa butter contains phospholipids, which make it possible not to use synthetic toxic emulsifiers in production, and the presence of polyunsaturated fatty acids facilitates the introduction and dissolution of the drug.
Indications
- Acute respiratory viral infections, including influenza, incl. complicated by bacterial infection, pneumonia (bacterial, viral, chlamydial) in children and adults as part of complex therapy;
Infectious and inflammatory diseases of newborn children, incl. premature, such as meningitis (bacterial, viral), sepsis, intrauterine infection (chlamydia, herpes, cytomegalovirus infection, enterovirus infection, candidiasis, including visceral, mycoplasmosis), as part of complex therapy;
- chronic viral hepatitis B, C, D in children and adults as part of complex therapy, incl. in combination with the use of plasmapheresis and hemosorption in chronic viral hepatitis of severe activity complicated by cirrhosis of the liver;
- Infectious-inflammatory diseases of the urogenital tract (chlamydia, cytomegalovirus infection, ureaplasmosis, trichomoniasis, gardnerellez, papillomavirus infection, bacterial vaginosis, recurrent vaginal candidiasis, mycoplasmosis) in adults as part of complex therapy;
- primary or recurrent herpetic infection of the skin and mucous membranes, localized form, mild and moderate-to-moderate flow, incl. urogenital form in adults.


.